Consistent with our findings in nine human cancer cell lines, Plek2 knockdown significantly inhibited both proliferation and migration of LLC cells (Figures S7a and S7c), while Plek2 overexpression enhanced these abilities (Figures S7b and S7d). Here, PLEK2 is linked to cancer.